Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GPN vs GSK✓SelectedUSD · GSKGPN vs GSK performance historyLatest closeAs of-2.26%11/16
Stock and ETF performance explorer

GPN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+36.4%
GSK return
+107.3%
Excess return
-70.9%
Maximum drawdown
-70.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.3%-0.1%-2.2%-2.2%
7D-8.1%-1.3%-6.8%-7.6%
30D+7.4%+2.7%+4.6%+6.0%
3M-3.2%+2.7%-5.9%-4.6%
6M+33.8%+3.3%+30.5%+31.1%
YTD+17.2%+6.5%+10.7%+12.7%
1Y+22.8%+10.7%+12.1%+16.2%
3Y-17.0%+64.4%-81.3%-37.0%
5Y-27.0%+46.7%-73.7%-42.7%
10Y+36.4%+109.4%-73.0%-11.5%
All+36.4%+107.3%-70.9%-11.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling